Prestige Biologics Co (XKRX:334970) Price-to-Operating-Cash-Flow : (As of Jun. 17, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co Price-to-Operating-Cash-Flow?

As of today (2024-06-17), Prestige Biologics Co's share price is ₩4150.00. Prestige Biologics Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-102.85. Hence, Prestige Biologics Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Prestige Biologics Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 7 years, Prestige Biologics Co's highest Price-to-Operating-Cash-Flow Ratio was 268.25. The lowest was 220.99. And the median was 245.85.

XKRX:334970's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.38
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Prestige Biologics Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ₩-111.56. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-102.85.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 4.90% per year.

During the past 7 years, Prestige Biologics Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.70% per year. The lowest was -46.50% per year. And the median was -13.00% per year.

Prestige Biologics Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Prestige Biologics Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Biologics Co Price-to-Operating-Cash-Flow Chart

Prestige Biologics Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Prestige Biologics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	240.38	-

Competitive Comparison of Prestige Biologics Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Prestige Biologics Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Biologics Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige Biologics Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Prestige Biologics Co's Price-to-Operating-Cash-Flow falls into.

Prestige Biologics Co Price-to-Operating-Cash-Flow Calculation

Prestige Biologics Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	4150.00	/	-102.847
	=

Prestige Biologics Co's Share Price of today is ₩4150.00.
Prestige Biologics Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-102.85.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Prestige Biologics Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Biologics Co (XKRX:334970) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161

Website

https://www.prestigebiologics.com

Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co (XKRX:334970) Headlines

No Headlines